PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsGenetic factors important in survival after breast cancer, study shows

BioNews

Genetic factors important in survival after breast cancer, study shows

Published 6 August 2010 posted in News and appears in BioNews 570

Author

Sarah Pritchard

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

A UK study has revealed that breast cancer patients who have the POLQ gene are eight times more likely to suffer from recurrence after treatment compared to patients who do not carry the gene....

A UK study has revealed that breast cancer patients who have the POLQ gene are eight times more likely to suffer from recurrence after treatment compared to patients who do not carry the gene.

A lack of the gene DNA polymerase theta (POLQ) has previously been shown to make tumour cells more sensitive to radiotherapy.

Scientists based at the Cancer Research UK/MRC Gray Institute for Radiation Oncology and Biology at Oxford University investigated whether 279 women with breast cancer who over-expressed POLQ had worse outcomes than women who did not. The team reported that excessive POLQ was associated with an 8.1 times higher risk of poor survival, which was independent of other clinical features of the women's cancer including how big their tumours were and how old they were.

'This is important research which provides evidence that POLQ may be a very appealing target for drug development', said Professor Gillies McKenna, director of the Institute.

'As POLQ is not switched on by most healthy tissues it is possible that if drugs could be developed to block this gene, they would make tumours more responsive to treatments such as radiotherapy and chemotherapy, but not increase the side effects caused to healthy cells'.

The researchers are unsure as to why POLQ is linked to poor survival, but they suggest that it could cause tumour cells to be resistant to treatments including radiotherapy, which are frequently used to treat breast cancer patients with early stage disease. POLQ could also induce tumour cells to behave more aggressively than cancers that do not express the gene.

'Drugs that block POLQ may be able to reverse the very poor survival associated with over production of this gene', added Professor McKenna.

In 2007, almost 45,700 women in the UK were diagnosed with breast cancer, according to figures from Cancer Research UK.

Dr Lesley Walker, science information director at the charity said: ‘Fundamental scientific research like this to examine the genetic causes for breast cancer provides us with the foundations to develop new exciting drugs to beat the disease and increase survival in the future'.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
1 November 2012 • 2 minutes read

Genetic test for cancer may reduce need for screening

by Dr Kimberley Bryon-Dodd

Screening for breast and prostate cancer based on genetic risk factors as well as age could reduce the number of people screened without a significant reduction in the number of cancers detected, a new study suggests....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
1 November 2012 • 2 minutes read

Genetic test may help to predict treatment success in breast cancer

by Dr Jay Stone

US scientists have designed a genetic test which could predict how a patient with breast cancer responds to chemotherapy. Researchers say the test, which works for those with certain newly diagnosed forms of cancer, could help women avoid unnecessary chemotherapy....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
17 October 2012 • 1 minute read

New gene treatment for breast cancer developed

by Dr Jay Stone

Scientists at Queen's University, Belfast, have developed a new targeted gene therapy for the treatment of breast cancer....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 September 2010 • 1 minute read

Genome maps could help predict risk of breast cancer

by Dr Christopher Chatterton and 1 others

A group of international researchers have become the first to link the cumulative effects of single nucleotide polymorphisms (SNP) in genes responsible for the production of oestrogen, to a woman's risk of developing common breast and uterine cancers....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
14 June 2010 • 2 minutes read

Gene patent for breast cancer faces legal challenge

by MacKenna Roberts

The Australian Federal Court in Sydney is considering groundbreaking legal action of whether private companies can obtain patents on human genes....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
7 June 2010 • 1 minute read

Environmental factors do not heighten the genetic risks of breast cancer

by Dr Tamara Hirsch

Women who inherit genes linked to breast cancer have no greater risk than other women of developing the disease as a result of lifestyle choices, including hormone replacement therapy (HRT) and alcohol consumption, according to a recent study in The Lancet....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
19 October 2009 • 1 minute read

World's largest breast cancer study will recruit 60,000 women

by Rosie Beauchamp

A research team led by Professor Gareth Evans at theNightingale Centre and Genesis Prevention Centre based in the Wythenshawe Hospital in Greater Manchester, UK, will carry out the biggest ever study to look at the causes of breast cancer with the aim of improving screening and diagnosis. One in 10 women in the UK develop breast cancer with 44,000 diagnoses a year, making it the most common cancer in British women....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
31 July 2009 • 2 minutes read

Hope for new drug to treat inherited breast, ovarian and prostate cancers

by Dr Rebecca Robey

A new drug for the treatment of inherited forms of breast, ovarian and prostate cancer has shown promising results in early clinical trials. The study, published in the New England Journal of Medicine, reported that the drug promoted tumour reduction and clinical improvement in advanced-stage cancer patients whilst causing fewer side effects than conventional chemotherapy....

Leave a Reply Cancel reply

You must be logged in to post a comment.

« New genetic markers linked to breast cancer risk

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856